Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05923359 · ClinicalTrials.gov registry record · NA

Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)

A NA study of Atrial Fibrillation, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
2,000
Enrollment target
1
Study location

NCT05923359 is a NA study of Atrial Fibrillation that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 2,000 participants, below the 2,987-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05923359, a NA study of Atrial Fibrillation, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.

Conditions Studied

Atrial Fibrillation

Interventions

  • OTHER Apple Watch

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-04-10
Est. Completion 2026-09
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05923359

The ClinicalTrials.gov registry entry for NCT05923359 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,987-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (33% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Apple Watch is the first listed.

NCT05923359 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05923359 about?

NCT05923359 is a clinical study titled "Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)". The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.

What is the current status of trial NCT05923359?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2024-04-10. Estimated completion is 2026-09.

What conditions does trial NCT05923359 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05923359?

The interventions under investigation include: Apple Watch (OTHER).

Who is sponsoring clinical trial NCT05923359?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05923359 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.